The co-developer of one of the two major m-RNA vaccines against Covid-19, BioNtech, is not only reaping the rewards of its innovative, life-saving work. It’s creating brand new possibilities in its home city, Mainz, in southwestern Germany.
Location / R&D
As part of the drive toward carbon neutrality, the German Ministry of Education and Research has created a new EUR 20 million fund to encourage the development of “methods for the removal of atmospheric carbon dioxide.” The program will be available to research projects for the next three years.
Scientists at Materials Research Department of GSI Helmholtzzentrum für Schwerionenforschung (Helmholtz Center for Heavy Ion Research), working together with colleagues from Argentina and the US, have come up with a sensor that can detect SARS-Cov-2 and other virus within two hours from saliva, serum and wastewater samples.
Political VIPs turned out for a tape-cutting ceremony at Amazon’s new research and development facility in the Saxon city of Dresden.
The place to be for young entrepreneurs into 5G right now is Munich’s Wayra 5G Tech Lab, a project created by the Telefónica/O2’s in-house start up accelerator, Wayra Germany.
The German co-developer of one of the world’s leading coronavirus vaccines, BioNTech, is training its sights on other infectious diseases, including malaria. In late July, the company from the southwestern city of Mainz launched its “malaria project” that aims produce a safe and effective vaccine by the end of 2022.
A private company, a respected university and the police in the eastern regional state of Saxony-Anhalt have come up with a digital 3D analysis system to help emergency responders better deal with crisis situations such as terrorist attacks, fires and natural catastrophes.
One of Germany’s top scientific institutes – the Helmholtz Association – has come in second around the world in the 2021 Rising Stars Index of increased research productivity.
Rare but serious cases of blood clotting in people inoculated by the vector vaccines produced by AstraZeneca and Johnson&Johnson have been one obstacle to the international immunization campaigns against Covid-19.
Three years from now, when NASA’s Orion spacecraft heads for the moon, technology made in northern Germany will help it get there.